Lepu Medical Technology (Beijing) Past Earnings Performance
Past criteria checks 1/6
Lepu Medical Technology (Beijing)'s earnings have been declining at an average annual rate of -4%, while the Medical Equipment industry saw earnings growing at 5.1% annually. Revenues have been growing at an average rate of 2.2% per year. Lepu Medical Technology (Beijing)'s return on equity is 5.6%, and it has net margins of 14.1%.
Key information
-4.0%
Earnings growth rate
-5.0%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 2.2% |
| Return on equity | 5.6% |
| Net Margin | 14.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat
Aug 31
Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts
Aug 27Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively
Aug 16Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314
Jun 23Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly
May 31Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal
May 13Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet
Feb 28Revenue & Expenses Breakdown
How Lepu Medical Technology (Beijing) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 7,062 | 994 | 2,258 | 794 |
| 31 Mar 24 | 7,465 | 1,143 | 2,305 | 847 |
| 31 Dec 23 | 7,980 | 1,258 | 2,467 | 879 |
| 30 Sep 23 | 9,107 | 1,747 | 2,777 | 960 |
| 30 Jun 23 | 9,577 | 1,897 | 2,803 | 959 |
| 31 Mar 23 | 10,498 | 2,254 | 2,790 | 974 |
| 31 Dec 22 | 10,609 | 2,204 | 2,802 | 957 |
| 30 Sep 22 | 9,787 | 1,608 | 2,768 | 975 |
| 30 Jun 22 | 9,473 | 1,262 | 2,741 | 974 |
| 31 Mar 22 | 10,460 | 1,539 | 2,859 | 955 |
| 01 Jan 22 | 10,660 | 1,719 | 2,871 | 908 |
| 30 Sep 21 | 10,286 | 1,750 | 2,540 | 875 |
| 30 Jun 21 | 10,321 | 2,387 | 2,714 | 812 |
| 31 Mar 21 | 9,121 | 2,144 | 2,584 | 774 |
| 31 Dec 20 | 8,039 | 1,802 | 2,484 | 736 |
| 30 Sep 20 | 8,303 | 2,086 | 2,621 | 653 |
| 30 Jun 20 | 8,112 | 1,710 | 2,599 | 591 |
| 31 Mar 20 | 7,584 | 1,526 | 2,694 | 563 |
| 31 Dec 19 | 7,796 | 1,725 | 2,792 | 544 |
| 30 Sep 19 | 7,652 | 1,687 | 2,864 | 469 |
| 30 Jun 19 | 7,323 | 1,564 | 2,791 | 455 |
| 31 Mar 19 | 6,799 | 1,498 | 2,643 | 405 |
| 31 Dec 18 | 6,356 | 1,219 | 2,481 | 376 |
| 30 Sep 18 | 5,832 | 1,304 | 2,137 | 345 |
| 30 Jun 18 | 5,310 | 1,214 | 1,750 | 406 |
| 31 Mar 18 | 4,942 | 970 | 1,644 | 315 |
| 31 Dec 17 | 4,538 | 899 | 1,467 | 235 |
| 30 Sep 17 | 4,234 | 874 | 1,336 | 154 |
| 30 Jun 17 | 3,974 | 797 | 1,333 | 0 |
| 31 Mar 17 | 3,701 | 734 | 1,225 | 0 |
| 31 Dec 16 | 3,468 | 679 | 1,130 | 0 |
| 30 Sep 16 | 3,318 | 649 | 1,034 | 0 |
| 30 Jun 16 | 3,113 | 610 | 942 | 0 |
| 31 Mar 16 | 2,938 | 569 | 851 | 0 |
| 31 Dec 15 | 2,769 | 521 | 781 | 0 |
| 30 Sep 15 | 2,419 | 520 | 671 | 0 |
| 30 Jun 15 | 2,208 | 500 | 622 | 0 |
| 31 Mar 15 | 1,934 | 458 | 564 | 0 |
| 31 Dec 14 | 1,669 | 423 | 528 | 0 |
| 30 Sep 14 | 1,578 | 405 | 510 | 0 |
| 30 Jun 14 | 1,490 | 385 | 504 | 0 |
| 31 Mar 14 | 1,375 | 362 | 494 | 0 |
| 31 Dec 13 | 1,303 | 362 | 476 | 0 |
| 30 Sep 13 | 1,215 | 353 | 439 | 0 |
Quality Earnings: 300003 has high quality earnings.
Growing Profit Margin: 300003's current net profit margins (14.1%) are lower than last year (19.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300003's earnings have declined by 4% per year over the past 5 years.
Accelerating Growth: 300003's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300003 had negative earnings growth (-47.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (-3.5%).
Return on Equity
High ROE: 300003's Return on Equity (5.6%) is considered low.